|
|
|
Insider
Information: |
Hopfner Robert Lorne |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
5,244,570 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
5,244,570 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vaxcyte, Inc. |
PCVX |
Director |
2020-06-16 |
0 |
2021-02-10 |
1,405,418 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
|
2020-07-28 |
0 |
2023-08-01 |
1,571,741 |
Premium* |
|
Rallybio Corp |
RLYB |
Director |
2021-07-28 |
0 |
2021-08-02 |
2,267,411 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
34 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PCVX |
Vaxcyte, Inc. |
Director |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,129,967 |
2,129,967 |
0 |
- |
|
INZY |
Inozyme Pharma, Inc. |
Director |
|
2020-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,403,654 |
1,403,654 |
0 |
- |
|
RLYB |
Rallybio Corp |
Director |
|
2021-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,694,388 |
1,694,388 |
0 |
- |
|
INZY |
Inozyme Pharma, Inc. |
Director |
|
2022-04-19 |
4 |
B |
$3.69 |
$3,948,300 |
I/I |
1,070,000 |
2,661,154 |
2.1 |
- |
|
INZY |
Inozyme Pharma, Inc. |
Director |
|
2023-03-27 |
4 |
B |
$3.70 |
$188,729 |
I/I |
51,074 |
2,712,228 |
2.1 |
- |
|
INZY |
Inozyme Pharma, Inc. |
Director |
|
2023-03-28 |
4 |
B |
$4.16 |
$652,335 |
I/I |
156,766 |
2,868,994 |
2.1 |
- |
|
INZY |
Inozyme Pharma, Inc. |
Director |
|
2023-03-29 |
4 |
B |
$4.54 |
$1,563,724 |
I/I |
344,592 |
3,213,586 |
2.1 |
- |
|
INZY |
Inozyme Pharma, Inc. |
|
|
2023-08-01 |
4 |
B |
$4.80 |
$3,999,998 |
I/I |
833,333 |
1,571,741 |
0.01 |
- |
|
INZY |
Inozyme Pharma, Inc. |
Director |
|
2023-05-12 |
4 |
B |
$6.25 |
$1,429,388 |
I/I |
228,702 |
3,661,518 |
2.1 |
- |
|
INZY |
Inozyme Pharma, Inc. |
Director |
|
2023-05-11 |
4 |
B |
$6.48 |
$1,420,610 |
I/I |
219,230 |
3,432,816 |
2.1 |
- |
|
RLYB |
Rallybio Corp |
Director |
|
2021-08-02 |
4 |
B |
$13.00 |
$7,499,999 |
I/I |
576,923 |
2,267,411 |
2.1 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2020-06-16 |
4 |
B |
$16.00 |
$1,488,000 |
I/I |
93,000 |
2,222,967 |
2.1 |
- |
|
INZY |
Inozyme Pharma, Inc. |
Director |
|
2020-07-28 |
4 |
B |
$16.00 |
$3,000,000 |
I/I |
187,500 |
1,591,154 |
2.25 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-02-03 |
4 |
AS |
$25.06 |
$69,366 |
I/I |
(2,768) |
1,784,116 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-01-28 |
4 |
AS |
$25.07 |
$50,140 |
I/I |
(2,000) |
1,801,118 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-01-21 |
4 |
AS |
$25.11 |
$2,511 |
I/I |
(100) |
1,869,755 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-02-02 |
4 |
AS |
$25.13 |
$357,700 |
I/I |
(14,234) |
1,786,884 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-01-22 |
4 |
AS |
$25.16 |
$286,396 |
I/I |
(11,383) |
1,858,372 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-01-26 |
4 |
AS |
$25.23 |
$458,958 |
I/I |
(18,142) |
1,805,258 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-01-27 |
4 |
AS |
$25.30 |
$54,142 |
I/I |
(2,140) |
1,803,118 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-01-20 |
4 |
AS |
$25.35 |
$482,816 |
I/I |
(19,046) |
1,869,855 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-01-11 |
4 |
AS |
$25.42 |
$1,313,764 |
I/I |
(49,666) |
2,027,689 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-01-19 |
4 |
AS |
$25.55 |
$1,268,634 |
I/I |
(49,516) |
1,888,901 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-01-25 |
4 |
AS |
$25.61 |
$902,745 |
I/I |
(34,972) |
1,823,400 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2021-02-08 |
4 |
AS |
$25.64 |
$2,058,117 |
I/I |
(79,796) |
1,704,320 |
0 |
- |
|
34 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|